High Prevalence of Chronic Disorders and R&D in Stem Cells to Augment Growth of Stem Cells Market
Stem cells are basically cells with the capacity to turn into different kinds of cells. These cells are used in the manufacture of blood, skin, heart, lungs, pancreas and a variety of other organs. They play an important role in organ transplants, tissue engineering and in the therapy of Parkinson's disease.
In fact, stem cells
harvested from the adult marrow have already helped treat some of these
diseases. Scientists have succeeded in transplanting adult stem cells from the
anogenital area of the male reproductive organ to patients with chronic
diseases like Parkinson's disease, a disease that affects both the nervous and
the cardiac systems. This procedure has proven to be very effective in treating
the disease since it stimulates the production of the living cells in the
diseased area. Since adult stem cells could help treat Parkinson's disease, the
researchers tested their idea in animals and succeeded. Stem cells from the
adult bone marrow have also shown great potential in treating diseases like
arthritis, psoriasis and multiple sclerosis.
Market
Dynamics
High prevalence of
chronic disorders is expected to propel growth of the global stem cells market.
For instance, according to the study, ‘Prevalence of Parkinson’s disease (PD)
across North America”, published in July 2018 in the journal Nature, the number
of people suffering from PD is expected to reach 930,000 in 2020 and 1,238,000
in 2030.
R&D in stem cells
is expected to offer lucrative growth opportunities for players in the global
stem cells market. For instance, in December 2020, researchers from the Wake
Forest Institute for Regenerative Medicine demonstrated that stem cells found
in amniotic fluid meet an essential test increasing their likelihood of
becoming specialized cell types.
Competitive
Analysis
Major players operating
in the global stem cells market include, Advanced Cell Technology, Inc., Angel
Biotechnology Holdings PLC, Bioheart Inc., Lineage Cell Therapeutics., BrainStorm
Cell Therapeutics, Inc., California Stem Cell Inc., Global Stem Cells Group, Celgene
Corporation, Takara Bio Europe AB, Cellular Engineering Technologies, Cytori
Therapeutics Inc., Osiris Therapeutics, and STEMCELL Technologies Inc.
Major players operating
in the global stem cells market are focused on adopting M&A strategies to
enhance their market share. For instance, in October 2020, Global Stem Cells
Group signed an agreement with Bioscience Cell Factory, a Dubai-based
healthcare company, which will allow GSCG to act as their representatives
operating in both the Middle East and Latin America.
Comments
Post a Comment